Clinical Trial

Effect of Metformin Iontophoresis on Knee Osteoarthritis in Postmenopausal Women

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated February 9, 2026 (before its estimated April 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is designed as a randomized, double-blind, placebo-controlled clinical trial with two parallel groups. All participants will receive a standardized physical therapy rehabilitation program. Participants will be randomly allocated into either a study group receiving metformin iontophoresis or a control group receiving placebo iontophoresis. Both participants and outcome assessors will be blinded to group allocation.
Trial Details
NCT Number NCT07395895
Lead Sponsor Badr University
Conditions Osteoarthritis in Postmenopausal Women
Enrollment 68 participants
Start Date 2026-03-01
Primary Completion 2026-04-15 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-09